Oct 30, 2025 04:16PM
Oct 30, 2025 04:15PM
Oct 30, 2025 07:01AM
Oct 30, 2025 07:00AM
Oct 29, 2025 06:00AM
Oct 29, 2025 06:00AM
Oct 29, 2025 03:53AM NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem's Shares
Oct 27, 2025 07:00AM
Oct 27, 2025 07:00AM
Oct 23, 2025 06:03AM
Oct 23, 2025 06:01AM
Sep 30, 2025 07:01AM
Sep 30, 2025 07:00AM
Sep 10, 2025 06:00AM Kadimastem and NLS Pharmaceutics Announce Effectiveness of SEC Registration Statement in Connection with Proposed Merger
Apr 15, 2025 09:02AM
Apr 15, 2025 09:00AM
Jan 28, 2025 07:32AM
Jan 28, 2025 07:30AM
Dec 11, 2024 07:32AM
Dec 11, 2024 07:30AM
Nov 18, 2024 07:30AM NLS Pharmaceutics Highlights Innovative Preclinical Program for First-in-Class Non-Sulfonamide Dual Orexin Receptor Agonists (DOXA) in Narcolepsy and Neurological Disorders
Mar 20, 2024 07:34AM
Mar 20, 2024 07:30AM
Dec 1, 2023 07:30AM

1,157,989 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All